{"id":"flumecinol","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"zixoryn","offLabel":[],"synonyms":["flumatsynol","flumacinol","flumecinol","zixoryn","RGH-3332"],"timeline":[],"approvals":[],"brandName":"Zixoryn","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a city with many different roads and intersections. Zixoryn is like a traffic cop that tries to direct the flow of traffic, but we don't know which roads it's trying to control or how it's doing it. This is a simplified way of understanding how Zixoryn might work, but the actual details are much more complex.","oneSentence":"Zixoryn works by interacting with specific biological pathways, but the exact mechanism is unknown.","technicalDetail":"As a small molecule, Zixoryn is likely to work through specific molecular interactions, such as binding to a particular protein or receptor, which would alter the downstream signaling pathways and ultimately lead to its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1196","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUMECINOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:33:19.852873","biosimilars":[],"competitors":[],"genericName":"flumecinol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"JB0YA8LDOW","CHEBI":"CHEBI:135160","INN_ID":"4445","UMLSCUI":"C0060491","ChEMBL_ID":"CHEMBL2107440","PUBCHEM_CID":"41870","MESH_SUPPLEMENTAL_RECORD_UI":"C016914"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":30,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Zixoryn (FLUMECINOL) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to determine its efficacy and safety profile. Its development and ownership history are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}